China Chinese Patent Medicine Industry Report, 2012-2015
  • Apr.2013
  • Hard Copy
  • USD $2,200
  • Pages:88
  • Single User License
    (PDF Unprintable)       
  • USD $2,100
  • Code: WLQ001
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,300
  • Hard Copy + Single User License
  • USD $2,400
      
In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Over the same period, the total profit maintained a CAGR of 26.6%, and the gross margin remained higher than the average level of the overall pharmaceutical industry.

In succession to the Opinions on Promoting the Development of Traditional Chinese Medicine Services and Trade, the Twelfth Five-Year Plan on the Development of Traditional Chinese Medicine and other favorable policies, the new National Essential Drugs List published in March 2013 increased the number of Chinese patent medicine from 102 in 2009 to 203, and the proportion in total quantity from 33% to 39%. As a result, China’s Chinese patent medicine market demand is expected to grow rapidly in the next five years.

Revenue and YoY Growth Rate of China’s Chinese Patent Medicine Industry, 2008-2012
?20130094.png

Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases, musculoskeletal diseases and digestive system diseases are top five categories of Chinese patent medicine for hospitals in China. The Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases occupies the largest market share, which remained at around 37% in 2006-2012. Outstanding enterprises producing Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases include Shandong Buchang Pharma (products include Guanxin Shutong Capsule and Naoxinshu Oral Solution), Tianjin Tasly Group (products include Compound Danshen Dripping Pills and Yangxue Qingnao Granule), Jinling Pharmaceutical (products include Mailuoning Injection and Mailuoning Oral Solution), Shijiazhuang Yiling Pharmaceutical (products include Tongxinluo Capsule and Shensong Yangxin Capsule), etc.

As China's Chinese patent medicine is gaining international recognition, coupled with the incentive from high profit (the operating margin is generally above 70%) and the development bottleneck of the chemical pharmaceutical industry, foreign enterprises and institutions such as Novartis, Merck, Johnson & Johnson, GSK have set foot in the Chinese patent medicine market through joint ventures and wholly-owned subsidiaries. For example, in early 2013, GSK announced to carry out drug development trying to use traditional Chinese medicinal ingredients in China.

China Chinese Patent Medicine Industry Report, 2012-2015 of ResearchInChina mainly includes the following contents:

20120114.gif Industrial policies, development status, regional market, import and export, development trend of China’s Chinese patent medicine industry;
20120114.gif Development status of the raw material market of China’s Chinese patent medicine industry as well as the development status and import & export of China’s plant extracts;
20120114.gif China’s Chinese patent medicine market segments, including Chinese patent medicine for the treatment of cardiovascular and cerebrovascular diseases, tumor diseases, respiratory system diseases, etc.;
20120114.gif Operation, revenue structure, gross margin and profit forecast of China's 10 major Chinese patent medicine production enterprises.

1. Overview of Chinese Patent Medicine
1.1 Definition and Features
1.2 Classification
1.2.1 Classification by Dosage Form
1.2.2 Classification by Pharmacology 
1.2.3 Industry Chain

2. Operating Environment for Chinese Patent Medicine Industry
2.1 Policies 
2.1.1 Domestic Policies 
2.1.2 Foreign Policies 
2.2 Consumption Trend
2.3 Industry Trend

3. Market of Chinese Patent Medicine Industry 
3.1 Development Status 
3.2 Supply and Demand 
3.2.1 Supply 
3.2.2 Demand 
3.3 Regional Market 
3.4 Import and Export 
3.4.1 Export 
3.4.2 Import 
3.5 Demand Trend 
3.5.1 Overview of Pharmaceutical Demand 
3.5.2 Population Aging Promotes Market Demand of Pharmaceutical Industry 
3.5.3 Urbanization Increases Healthcare Market Demand 
3.5.4 Disease Trend
3.6 Traditional Chinese Medicinal Materials 
3.6.1 Resources 
3.6.2 Price Trend 
3.7 Plant Extract 
3.7.1 Development Status
3.7.2 Import and Export 

4. Chinese Patent Medicine Market Segments in China
4.1 Overview 
4.2 Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases 
4.3 Chinese Patent Medicine for Tumor Diseases 
4.4 Chinese Patent Medicine for Respiratory System Diseases 
4.5 Chinese Patent Medicine for Musculoskeletal Diseases

5. Key Producers of Chinese Patent Medicine
5.1 Tianjin Tasly Pharmaceutical Co., Ltd. 
5.1.1 Profile 
5.1.2 Operation 
5.1.3 Revenue Structure 
5.1.4 Gross Margin 
5.1.5 Development Prospect 
5.2 Guizhou Yibai Pharmaceutical Co., Ltd. 
5.2.1 Profile 
5.2.2 Operation 
5.2.3 Revenue Structure 
5.2.4 Gross Margin 
5.2.5 Development Prospect 
5.3 Yunnan Baiyao Group Co., Ltd. 
5.3.1 Profile 
5.3.2 Operation 
5.3.3 Revenue Structure 
5.3.4 Gross Margin 
5.3.5 Development Prospect 
5.4 Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. 
5.4.1 Profile 
5.4.2 Operation 
5.4.3 Revenue Structure 
5.4.4 Gross Margin 
5.4.5 Development Prospect 
5.5 Shandong Dong-E E-Jiao Co., Ltd. 
5.5.1 Profile 
5.5.2 Operation 
5.5.3 Revenue Structure 
5.5.4 Gross Margin 
5.5.5 Development Prospect 
5.6 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu) 
5.6.1 Profile 
5.6.2 Operation 
5.6.3 Revenue Structure 
5.6.4 Gross Margin 
5.6.5 Development Prospect 
5.7 Shanghai Kaibao Pharmaceutical Co., Ltd. 
5.7.1 Profile 
5.7.2 Operation 
5.7.3 Revenue Structure 
5.7.4 Gross Margin 
5.7.5 Development Prospect 
5.8 Kangmei Pharmaceutical Co., Ltd. 
5.8.1 Profile 
5.8.2 Operation 
5.8.3 Revenue Structure 
5.8.4 Gross Margin 
5.8.5 Development Prospect 
5.9 Tibet Rhodiola Pharmaceutical Holding Co., Ltd. 
5.9.1 Profile 
5.9.2 Operation 
5.9.3 Revenue Structure 
5.9.4 Gross Margin 
5.9.5 Development Prospect 
5.10 Beijing Tongrentang Co., Ltd. (TRT) 
5.10.1 Profile 
5.10.2 Operation 
5.10.3 Revenue Structure 
5.10.4 Gross Margin 
5.10.5 Development Prospect 

Advantages and Disadvantages of Chinese Patent Medicine 
Classification of Chinese Patent Medicine by Dosage Form
Classification of Chinese Patent Medicine by Pharmacology 
Chinese Patent Medicine Industry Chain
Chinese Patent Medicine-related National Policies 
Number of Chinese Patent Medicine Enterprises in China, 2008-2012
Revenue and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2008-2012 
Total Profit and YoY Growth Rate of Chinese Patent Medicine Industry in China, 2008-2012 
Gross Margin of Chinese Patent Medicine Enterprises in China, 2011-2012 
Output and YoY Growth Rate of Chinese Patent Medicine in China, 2008-2012
Output of Top 10 Chinese Patent Medicine Producing Regions in China, 2012
Sales of Top 10 Chinese Patent Medicine Sales Regions in China, 2011
Sales Structure of Top 10 Chinese Patent Medicine Sales Regions in China, 2011
Top 10 Chinese Provinces/Municipalities by Number of Above-scale Chinese Patent Medicine Enterprises, 2012
Top 10 Chinese Provinces/Municipalities by Sales of Chinese Patent Medicine Enterprises, 2012
Top 10 Chinese Provinces/Municipalities by Total Profit of Chinese Patent Medicine Enterprises, 2012
Chinese Provinces/Municipalities with Gross Margin of Chinese Patent Medicine Enterprises Above 40%, 2012
Number of Enterprises, Sales and Total Profit of China’s Chinese Patent Medicine Market by Region, 2012
China’s Chinese Patent Medicine Export Volume and YoY Growth Rate, 2008-2012
China’s Chinese Patent Medicine Export Value and YoY Growth Rate, 2008-2012
China’s Chinese Patent Medicine Export Destinations, Export Value and Products, 2012
China’s Chinese Patent Medicine Export Destination Structure by Export Value, 2012
China’s Chinese Patent Medicine Export Products, Export Volume and Export Destinations, 2012
China’s Top 10 Chinese Patent Medicine Export Enterprises, 2011
China’s Top 5 Chinese Patent Medicine Export Enterprises, 2012 
China’s Chinese Patent Medicine Import Value and YoY Growth Rate, 2008-2012 
Revenue and Share in Pharmaceutical Industry of China’s Chinese Patent Medicine Industry, 2008-2012
China’s Population Aged 65 and Above, 2002-2012
Per Capita Healthcare Expenditure of China’s Urban and Rural Residents, 2001-2011
China’s Number of Hospitals and CAGR, 2001-2011
China’s Panax Notoginseng Price, 2008-2012
Trend Chart of Traditional Chinese Medicinal Material Comprehensive 200 Index, 2007-2012
Price Index of Traditional Chinese Medicinal Materials in Chengdu, China, 2010-2012
Major Traditional Chinese Medicinal Material GAP Enterprises in China, 2012
China’s Plant Extract Import and Export Value, 2008-2012
China’s Plant Extract Export Destination Structure by Export Value, 2012
Share of Chinese Patent Medicine in the Medicine Sold to Hospitals in China by Disease, 2011
Four Major Types of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases
Share of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011
Excellent Brands of Chinese Patent Medicine for Cardiovascular and Cerebrovascular Diseases, 2012
Share of Chinese Patent Medicine for Tumor Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011
Top 10 Excellent Brands of Chinese Patent Medicine for Tumor Diseases in China, 2012
Share of Chinese Patent Medicine for Respiratory System Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011
Chinese Patent Medicine for Respiratory System Diseases in Sample Hospital by Type, 2009
Excellent Brands of Chinese Patent Medicine for Respiratory System Diseases, 2012
Share of Chinese Patent Medicine for Musculoskeletal Diseases in the Chinese Patent Medicine Sold to Hospitals in China, 2007-2011
China’s Top 10 Excellent Brands of Traditional Chinese Medicine for Musculoskeletal Diseases, 2012
Revenue and YoY Growth Rate of Tasly, 2008-2012 
Net Income and YoY Growth Rate of Tasly, 2008-2012 
Revenue of Tasly by Sector, 2008-2012 
Revenue of Tasly by Region, 2008-2012 
Gross Margin of Tasly by Sector, 2008-2012 
Gross Margin of Tasly by Region, 2009-2012 
Revenue and Net Income of Tasly, 2011-2015 
Revenue and YoY Growth Rate of Yibai Pharmaceutical, 2008-2012
Net Income and YoY Growth Rate of Yibai Pharmaceutical, 2008-2012
Revenue of Yibai Pharmaceutical by Sector, 2009-2012 
Revenue of Yibai Pharmaceutical by Product, 2008-2012 
Revenue of Yibai Pharmaceutical by Region, 2008-2012 
Gross Margin of Yibai Pharmaceutical by Sector, 2009-2012 
Gross Margin of Yibai Pharmaceutical by Product, 2008-2012 
Gross Margin of Yibai Pharmaceutical by Region, 2008-2012 
Revenue and Net Income of Yibai Pharmaceutical, 2011-2015 
Revenue and YoY Growth Rate of Yunnan Baiyao, 2008-2012 
Net Income and YoY Growth Rate of Yunnan Baiyao, 2008-2012 
Revenue of Yunnan Baiyao by Sector, 2008-2012 
Revenue of Yunnan Baiyao by Product, 2009-2012 
Revenue of Yunnan Baiyao by Region, 2008-2012
Gross Margin of Yunnan Baiyao by Sector, 2008-2012 
Gross Margin of Yunnan Baiyao by Product, 2009-2012 
Gross Margin of Yunnan Baiyao by Region, 2008-2012
Revenue and Net Income of Yunnan Baiyao, 2011-2015 
Revenue and YoY Growth Rate of Pientzehuang, 2008-2012
Net Income and YoY Growth Rate of Pientzehuang, 2008-2012 
Revenue of Pientzehuang by Sector, 2008-2012 
Revenue of Pientzehuang by Region, 2008-2012 
Gross Margin of Pientzehuang by Sector, 2008-2012 
Gross Margin of Pientzehuang by Product, 2008-2012 
Gross Margin of Pientzehuang by Region, 2008-2012 
Revenue and Net Income of Pientzehuang, 2011-2015 
Revenue and YoY Growth Rate of Dong-E E-Jiao, 2008-2012 
Net Income and YoY Growth Rate of Dong-E E-Jiao, 2008-2012 
Revenue of Dong-E E-Jiao by Product, 2008-2012 
Revenue of Dong-E E-Jiao by Region, 2008-2012 
Gross Margin of Dong-E E-Jiao by Product, 2008-2012 
Gross Margin of Dong-E E-Jiao by Region, 2009-2012 
Revenue and Net Income of Dong-E E-Jiao, 2011-2015 
Revenue and YoY Growth Rate of CR Sanjiu, 2008-2012 
Net Income and YoY Growth Rate of CR Sanjiu, 2008-2012 
Revenue of CR Sanjiu by Sector, 2008-2012 
Revenue of CR Sanjiu by Region, 2008-2012 
Gross Margin of CR Sanjiu by Sector, 2008-2012 
Revenue and Net Income of CR Sanjiu, 2011-2015
Revenue and YoY Growth Rate of Shanghai Kaibao, 2008-2012 
Net Income and YoY Growth Rate of Shanghai Kaibao, 2008-2012 
Revenue of Shanghai Kaibao by Product, 2008-2012 
Revenue of Shanghai Kaibao by Region, 2008-2012 
Gross Margin of Shanghai Kaibao by Product, 2008-2012 
Revenue and Net Income of Shanghai Kaibao, 2011-2015 
Revenue and YoY Growth Rate of Kangmei Pharmaceutical, 2008-2012 
Net Income and YoY Growth Rate of Kangmei Pharmaceutical, 2008-2012 
Revenue of Kangmei Pharmaceutical by Region, 2008-2012 
Gross Margin of Kangmei Pharmaceutical by Region, 2008-2012 
Revenue and Net Income of Kangmei Pharmaceutical, 2011-2015 
Revenue and YoY Growth Rate of Tibet Rhodiola Pharmaceutical, 2008-2012 
Net Income and YoY Growth Rate of Tibet Rhodiola Pharmaceutical, 2008-2012 
Revenue of Tibet Rhodiola Pharmaceutical by Product, 2008-2012 
Revenue of Tibet Rhodiola Pharmaceutical by Region, 2008-2012 
Gross Margin of Tibet Rhodiola Pharmaceutical by Sector, 2008-2012 
Gross Margin of Tibet Rhodiola Pharmaceutical by Product, 2008-2012 
Gross Margin of Tibet Rhodiola Pharmaceutical by Region, 2008-2012 
Revenue and Net Income of Tibet Rhodiola Pharmaceutical, 2011-2015 
Revenue and YoY Growth Rate of Tongrentang, 2008-2012 
Net Income and YoY Growth Rate of Tongrentang, 2008-2012 
Revenue of Tongrentang by Region, 2008-2012 
Gross Margin of Tongrentang by Region, 2009-2012 
Revenue and Net Income of Tongrentang, 2011-2015 

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统